Federated Hermes’s Connect Biopharma Holdings CNTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-12,000
Closed -$234K 2235
2021
Q2
$234K Sell
12,000
-28,000
-70% -$467K ﹤0.01% 1655
2021
Q1
$740K Buy
+40,000
New +$681K ﹤0.01% 1475

Other funds holding CNTB

Federated Hermes's CNTB Position: Q3 2021 in Review

Federated Hermes sold out of Connect Biopharma Holdings (CNTB) in Q3 2021, closing a stake of 12,000 shares — an estimated $234K sold.

Federated Hermes first reported a position in CNTB in Q1 2021 and held it in 2 quarters. The position peaked at $740K in Q1 2021. 20 funds tracked by Wall St. Rank hold CNTB as of Q3 2021.

  • Federated Hermes reported no remaining Connect Biopharma Holdings position as of Q3 2021 after selling out during the quarter.
  • Federated Hermes sold 12,000 Connect Biopharma Holdings shares in Q3 2021, an estimated $234K.
  • Federated Hermes first reported a position in Connect Biopharma Holdings in Q1 2021 and held it in 2 quarters.
  • Federated Hermes's Connect Biopharma Holdings position peaked at $740K in Q1 2021.
  • 20 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q3 2021.

Based on Federated Hermes's 13F filing for Q3 2021, filed 15 Nov 2021.